Managed IT for Bio Tech and Life Science: Protecting Intellectual Property
Biotech and life science companies live on a knife edge. Years of research and millions in funding hinge on the integrity of data, the reproducibility of results, and the timing of an IP filing. When a lab’s file server goes read-only during a CRISPR screen, or a collaborator emails a pre-publication dataset through a personal Gmail account, the issue is not just inconvenience. It can be an SEC disclosure, a blown patent window, or a clinical delay that ripples through an e
Continued inside
Biotech and life science companies live on a knife edge. Years of research and millions in funding hinge on the integrity of data, the reproducibility of results, and the timing of an IP filing. When a lab’s file server goes read-only during a CRISPR screen, or a collaborator emails a pre-publication dataset through a personal Gmail account, the issue is not just inconvenience. It can be an SEC disclosure, a blown patent window, or a clinical delay that ripples through an e
Read the full column